These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36119468)

  • 21. Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.
    Liu M; Liu S; Yang L; Wang S
    BMC Cancer; 2021 Feb; 21(1):118. PubMed ID: 33541289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Liu ZL; Zhu WR; Zhou WC; Ying HF; Zheng L; Guo YB; Chen JX; Shen XH
    J Integr Med; 2014 Jul; 12(4):346-58. PubMed ID: 25074884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Platinum-Containing Chemotherapies in Advanced Triple-Negative Breast Cancer: Meta-Analytical Approach to Evaluating Its Efficacy and Safety.
    Yang R; Shi YY; Han XH; Liu S
    Oncol Res Treat; 2021; 44(6):333-343. PubMed ID: 33975311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysis.
    Bian NN; Wang YH; Min GT
    Int J Surg; 2019 Feb; 62():34-43. PubMed ID: 30641155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer.
    Qi Y; Zhang W; Jiang R; Xu O; Kong X; Zhang L; Fang Y; Wang J; Wang J
    Front Pharmacol; 2022; 13():960323. PubMed ID: 36188589
    [No Abstract]   [Full Text] [Related]  

  • 26. Ixabepilone as monotherapy or in combination with capecitabine for the treatment of advanced breast cancer.
    Rak Tkaczuk KH
    Breast Cancer (Auckl); 2011 Jan; 5():1-14. PubMed ID: 21494397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy and safety of total neoadjuvant therapy versus neoadjuvant chemoradiotherapy in the treatment of locally advanced rectal cancer: a meta-analysis].
    Zhang YQ; Sun KG; Lu JY; Ma J; Yao N; Qin ZH; Yao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):531-538. PubMed ID: 35754218
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and safety of elemene combined with chemotherapy in advanced gastric cancer: A Meta-analysis.
    Liu Y; Chen L; Zhang R; Chen B; Xiang Y; Zhang M; Huang X; Zhang W; Chen X; Pan T; Yan L; Jin T; Liu S; Feng J; Duan T; Xie T; Lin S; Sui X
    Medicine (Baltimore); 2020 Mar; 99(11):e19481. PubMed ID: 32176081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
    Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kanglaite injection plus fluorouracil-based chemotherapy on the reduction of adverse effects and improvement of clinical effectiveness in patients with advanced malignant tumors of the digestive tract: A meta-analysis of 20 RCTs following the PRISMA guidelines.
    Song Q; Zhang J; Wu Q; Li G; Leung EL
    Medicine (Baltimore); 2020 Apr; 99(17):e19480. PubMed ID: 32332600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review and meta-analysis of Chinese herbal medicine as adjuvant treatment in advanced non-small cell lung cancer patients.
    Wang LC; Chang YY; Lee IC; Kuo HC; Tsai MY
    Complement Ther Med; 2020 Aug; 52():102472. PubMed ID: 32951722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of combining targeted therapy with pemetrexed or docetaxel as second-line treatment in patients with advanced non-small-cell lung cancer: a meta-analysis of 14 randomized controlled trials.
    Li X; Wang H; Lin W; Xu Q
    Curr Med Res Opin; 2014 Nov; 30(11):2295-304. PubMed ID: 24701984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of bevacizumab in patients with malignant melanoma: a systematic review and PRISMA-compliant meta-analysis of randomized controlled trials and non-comparative clinical studies.
    Han X; Ge P; Liu S; Yang D; Zhang J; Wang X; Liang W
    Front Pharmacol; 2023; 14():1163805. PubMed ID: 37521468
    [No Abstract]   [Full Text] [Related]  

  • 34. The efficacy and safety of combined ipilimumab and nivolumab versus ipilimumab in patients with Stage III/IV unresectable melanoma: A systematic review and meta-analysis.
    Zhu Y; Cheng H; Zhong M; Hu Y; Li Q; Gao X; Liu S
    J Cancer Res Ther; 2021 Dec; 17(7):1679-1688. PubMed ID: 35381739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kangai Injection Combined with Platinum-based Chemotherapy for the Treatment of Stage III/IV Non-Small Cell Lung Cancer: A Meta-analysis and Systematic Review of 35 Randomized Controlled Trials.
    Li H; Ji Y; Zhang S; Gao Z; Hu C; Jiang R; Chen M; Li G; Zhang X
    J Cancer; 2019; 10(21):5283-5298. PubMed ID: 31602279
    [No Abstract]   [Full Text] [Related]  

  • 36. Compound
    Li K; Cheng H; Shen W; Leung EL; Le S; Yu L; Xie H; Sui X; Zhu X; Wu Q
    Evid Based Complement Alternat Med; 2021; 2021():9535061. PubMed ID: 34956388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Efficacy and Safety of Traditional Medicine Preparations Combined With Chemotherapy for Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.
    Hu J; Jiang J; Liu R; Cheng M; Zhu G; He S; Shi B; Zhao Y; He Z; Yu H; Zhang X; Zheng H; Hua B
    Front Oncol; 2022; 12():828450. PubMed ID: 35280766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials.
    Li C; Hao M; Fang Z; Ding J; Duan S; Yi F; Wei Y; Zhang W
    Cancer Chemother Pharmacol; 2023 Mar; 91(3):203-217. PubMed ID: 36725727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer: A Network Analysis of Randomized Controlled Trials.
    Li X; Yan S; Yang J; Wang Y; Lv C; Li S; Zhao J; Yang Y; Zhuo M; Wu N
    Front Oncol; 2020; 10():574752. PubMed ID: 33585195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of continuous infusion of Rh-endostatin combined with platinum-based chemotherapy for advanced triple-negative breast cancer.
    Tan A; Wang H; Nong L; Jia Y; Liu Y; Zhong W; Qin F; Wang H; Tang J; Zhou W; Lu Y; Xie W
    Ann Palliat Med; 2021 Dec; 10(12):12101-12112. PubMed ID: 35016411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.